TRAW
TRAW
NASDAQ · Pharmaceuticals

Traws Pharma Inc

$0.84
-0.05 (-6.09%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,555.5% upside
Low Target $15.33
Average Target $22.24
High Target $34.90
Current Price $0.84
Current
$0.84
Target
$22.24
$15.33 $22.24 avg $34.90
Scenario Analysis
Bear Case
$15.33
1,730.4%
Low target
Base Case
$22.24
+2,555.5%
Avg target
Bull Case
$34.90
+4,067.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$3.27
-74.3% from high
52-Week Low
$0.64
+30.9% from low
Target vs 52W High
$22.24
+581.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%